Physician profile
Elizabeth A Bohn
NPI 1679721179
$1,085.82
in general payments reported to CMS, 2019-2025
19 companies · $36.89 in 2025
The $36.89 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $175 · 2022: $310 · 2023: $312 · 2024: $252 · 2025: $36.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $601.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $600.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $319.81 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Abbvie INC. | $165.27 | 2021-2025 | |
| Exact Sciences Corporation | $125.00 | 2023 | Cologuard Collection Kit |
| Lilly USA, LLC | $95.97 | 2021-2024 | Mounjaro, Zepbound, Trulicity |
| Glaxosmithkline, LLC. | $85.58 | 2021-2024 | Arexvy, Shingrix, Bexsero |
| Amgen INC. | $56.32 | 2023-2024 | Repatha, Otezla |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $44.34 | 2023 | Xifaxan |
| Biohaven Pharmaceutical Holding Company LTD. | $42.05 | 2022 | |
| Sanofi-Aventis U.S. LLC | $18.31 | 2022 | |
| Sanofi Pasteur INC. | $16.68 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $15.01 | 2024 | Airsupra |
| E.R. Squibb & Sons, L.L.C. | $13.34 | 2023 | |
| Otsuka America Pharmaceutical, INC. | $13.28 | 2024 | Rexulti |
| Pfizer INC. | $13.14 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.95 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $12.57 | 2021 | |
| Medicure Pharma INC. | $12.41 | 2021 | |
| Abbott Laboratories | $12.39 | 2022 | |
| Organon LLC | $11.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Bohn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.